Left atrial minimum volume index at cardiac MRI had incremental prognostic value beyond traditional risk factors in predicting major adverse cardiovascular events among participants with acute myocardial infarction.
8 May 2025 in European Heart Journal - Cardiovascular Imaging
Aims: Global extracellular volume (ECV) fraction independently predicts outcomes after ST-elevation myocardial infarction (STEMI), but microvascular injuries complicate its interpretation. This study aims to assess the prognostic value of ECV-derived radiomics [radiomics score (RadScore)] from cardiac magnetic resonance (CMR) for risk stratification in reperfused STEMI patients. Methods and results: We retrospectively included 441 reperfused STEMI patients (mean age 60 ± 11 years; 371 males) from two centres, divided into development (n = 347) and validation cohort (n = 94) by centres. CMR scan was performed 1 week within the index event. ECV mapping was obtained from pre- and post-contrast T1 mappings. RadScore was developed through radiomics analysis on ECV mapping, and its predictive performance for major adverse cardiovascular events (MACE) was evaluated via logistic and Cox regression analyses. Over a median 3.1-year follow-up, MACE occurred in 81 patients (18.4%). RadScore showed strong predictive capability with an area under the curve (AUC) of 0.865 [95% confidence interval (CI): 0.768–0.962] and 0.821 (95% CI: 0.701–0.940) on the internal and external test cohort, respectively, reclassifying 44% and 32% of patients over clinical model, respectively. Patients with RadScore above the optimal threshold (RS+) experienced a more than 12-fold increase in MACE risk (95% CI: 2.96–47.71, P < 0.001) after adjusting for known risk factors. RS + provides incremental prognostic value beyond LVEF. Conclusion: RadScore derived from ECV mapping was able to predict MACE and provided incremental prognostic value beyond established risk factors. Our findings underscore the potential long-term impact of acute changes in extracellular space patterns after myocardial infarction.
BACKGROUND: T2-weighted imaging is commonly used to measure myocardial salvage in reperfused myocardial infarction but is hindered by poor reproducibility and indistinct boundaries. Early gadolinium enhancement (EGE) emerges as an alternative for measuring the area at risk. This study aims to evaluate the determinants of the myocardial salvage index (MSI) derived from EGE and its prognostic implications. METHODS: We analyzed acute cardiac magnetic resonance scans of 453 reperfused patients with ST-segment–elevation myocardial infarction (mean age, 60±12 years; 389 men) from April 2017 to July 2023 at a single center retrospectively. EGE was collected at 3 minutes after contrast agent injection, where hyperintense areas (signal intensities > mean+2SD of remote myocardium) were considered as the area at risk, plus the hypointense core within. MSI was calculated as the ratio of salvageable myocardium to the area at risk. Major adverse cardiovascular events included cardiovascular death, hospitalization for heart failure, reinfarction, and unplanned revascularization for the target vessel. RESULTS: During a median follow-up of 3.2 years (interquartile range, 1.6–4.7 years), at least one major adverse cardiac event occurred in 91 participants (20.1%). The median MSI was 35.0% (interquartile range, 22.9–59.5%), with smaller MSI observed in patients with larger infarcts ( P <0.001). Linear regression identified prepercutaneous coronary intervention Thrombolysis in Myocardial Infarction flow (β=3.35, P <0.001) and microvascular obstruction (β=−11.92, P <0.001) as independent determinants of MSI. Multivariable Cox regression showed that every 10% increase in MSI was associated with a 32% reduction in major adverse cardiac event risk (hazard ratio, 0.68 [95% CI, 0.53–0.86]; P =0.001). A graded response was observed between MSI and cardiovascular death and reinfarction. MSI greater than the median was associated with nontarget vessel-related reinfarctions but not target vessel-related ones (nontarget, P =0.027; target vessel, P =0.36). Good reproducibility was reported with EGE-measured area at risk (intraobserver, intraclass correlation coefficient [ICC]=0.95; interobserver, ICC=0.89). CONCLUSIONS: EGE-derived MSI was associated with prepercutaneous coronary intervention Thrombolysis in Myocardial Infarction flow and microvascular injuries. It was an independent predictor of major adverse cardiac events. Our results highlight the prognostic potential of EGE imaging in acute myocardial infarction.
21 April 2026 in European Heart Journal - Cardiovascular Imaging
Aims: While previous studies suggest a cardio-splenic axis involving splenic activation and systemic inflammation, presence and clinical significance of splenic tissue alterations on cardiac magnetic resonance (CMR) in ST-segment–elevation myocardial infarction (STEMI) remain unclear. This study aims to identify determinants of splenic T1 patterns in STEMI and explore their association with adverse outcomes. Methods and results: This retrospective study enrolled STEMI patients undergoing CMR within 10 days after primary percutaneous coronary intervention (April 2017–October 2024). CMR evaluated infarction patterns, myocardial function, native splenic T1 times and extracellular volume (ECV). Major adverse cardiovascular events (MACE) included cardiovascular death, heart failure and myocardial re-infarction. Results were validated in a separate cohort. Associations between variables and outcomes were evaluated using Cox regression. The development and validation cohorts comprised 1037 (median age 60; 872 men) and 252 (median age 59; 212 men) patients, respectively. Over a median follow-up of 38 and 30 months, 207 and 40 MACE occurred. In multivariable Cox regression, both elevated splenic T1 z-score [adjusted hazard ratio (HR) 1.58] and splenic ECV (adjusted HR 1.22) independently predicted MACE, driven primarily by heart failure and non-target vessel re-infarction. The model combining clinical and conventional myocardial imaging risk factors with splenic T1 z-score demonstrated best discrimination among all tested models (development C index = 0.87; validation C index = 0.85). Conclusion: Elevated splenic T1 z-score and ECV assessed by CMR after STEMI independently predicted MACE, mainly because of higher risk of heart failure and non-target vessel re-infarction, providing incremental prognostic value over traditional clinical and imaging risk markers.